Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer

NCT01714765 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT01714765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01714765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer
Lead sponsor
Queen Mary University of London
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2011
Completion date
October 31, 2012
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic clear cell renal cancer